Phreesia/$PHR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Health
Primary listing
NYSE
Employees
2,082
Headquarters
Website
Phreesia Metrics
BasicAdvanced
$1.7B
-
-$0.73
0.74
-
Price and volume
Market cap
$1.7B
Beta
0.74
52-week high
$30.53
52-week low
$17.07
Average daily volume
490K
Financial strength
Current ratio
1.946
Quick ratio
1.499
Long term debt to equity
2.326
Total debt to equity
5.623
Interest coverage (TTM)
-16.58%
Profitability
EBITDA (TTM)
-22.117
Gross margin (TTM)
68.02%
Net profit margin (TTM)
-9.83%
Operating margin (TTM)
-8.51%
Effective tax rate (TTM)
-7.39%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-5.98%
Return on equity (TTM)
-15.97%
Valuation
Price to revenue (TTM)
3.727
Price to book
5.87
Price to tangible book (TTM)
13.19
Price to free cash flow (TTM)
73.896
Free cash flow yield (TTM)
1.35%
Free cash flow per share (TTM)
0.377
Growth
Revenue change (TTM)
16.29%
Earnings per share change (TTM)
-65.83%
3-year revenue growth (CAGR)
23.93%
3-year earnings per share growth (CAGR)
-37.96%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling
Business Wire·21 hours ago
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
Business Wire·2 weeks ago
Phreesia Named in Black Book Research's List of 2025's Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.7B as of August 13, 2025.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of August 13, 2025.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of August 13, 2025.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.